litlas
ログインアカウント作成

Jianping Weng

1999–2025 年に発表

147
論文数
19,664
被引用数
65
h 指数
130
i10 指数

被引用数

Jianping Weng の年別被引用数1987 年: 被引用 1 件1996 年: 被引用 1 件2000 年: 被引用 3 件2001 年: 被引用 7 件2002 年: 被引用 6 件2003 年: 被引用 5 件2004 年: 被引用 1 件2005 年: 被引用 4 件2006 年: 被引用 4 件2007 年: 被引用 6 件2008 年: 被引用 7 件2009 年: 被引用 10 件2010 年: 被引用 25 件2011 年: 被引用 68 件2012 年: 被引用 87 件2013 年: 被引用 102 件2014 年: 被引用 116 件2015 年: 被引用 112 件2016 年: 被引用 140 件2017 年: 被引用 116 件2018 年: 被引用 161 件2019 年: 被引用 543 件2020 年: 被引用 733 件2021 年: 被引用 778 件2022 年: 被引用 796 件2023 年: 被引用 614 件2024 年: 被引用 1,202 件2025 年: 被引用 710 件2026 年: 被引用 11 件1988〜1995 年は被引用が無いため表示していません1997〜1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 2,797 件、この内訳の 29%アメリカ合衆国: 引用元論文 1,386 件、この内訳の 14.4%イギリス: 引用元論文 540 件、この内訳の 5.6%イタリア: 引用元論文 365 件、この内訳の 3.8%オーストラリア: 引用元論文 290 件、この内訳の 3%ドイツ: 引用元論文 264 件、この内訳の 2.7%インド: 引用元論文 264 件、この内訳の 2.7%カナダ: 引用元論文 248 件、この内訳の 2.6%スペイン: 引用元論文 189 件、この内訳の 1.9%香港: 引用元論文 175 件、この内訳の 1.8%フランス: 引用元論文 170 件、この内訳の 1.8%韓国: 引用元論文 170 件、この内訳の 1.8%
0%29%その他 28.9%

機関

分野

  • Medicine70.2%
  • Biochemistry, Genetics and Molecular Biology18.2%
  • Immunology and Microbiology3.1%
  • Neuroscience1.2%
  • Health Professions1.1%
  • Nursing0.9%
  • その他5.3%

トピック

  • Diabetes Treatment and Management5.5%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.3%
  • Pancreatic function and diabetes3.3%
  • Diabetes Management and Research3.2%
  • Liver Disease Diagnosis and Treatment2.4%
  • Diabetes and associated disorders2.3%
  • その他79%

共著者

全論文

検索で開く
  1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

    著者: Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart, Jianping Weng - Pharmacological Reviews 2021 被引用: 1,080

  2. Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies

    著者: Xiumei Wu, Mengyun Xu, Mengya Geng, Shuo Chen, Peter J. Little, Suowen Xu, Jianping Weng - Signal Transduction and Targeted Therapy 2023 被引用: 237

  3. GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

    著者: Xiaoxuan Ma, Zhenghong Liu, Iqra Ilyas, Peter J. Little, Danielle Kamato, Amirhossein Sahebka, Zhengfang Chen, Sihui Luo, Xueying Zheng, Jianping Weng, Suowen Xu - International Journal of Biological Sciences 2021 被引用: 270

  4. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

    著者: Suowen Xu, Iqra Ilyas, Jianping Weng - Acta Pharmacologica Sinica 2022 被引用: 428

  5. Standards of medical care for type 2 diabetes in China 2019

    著者: Weiping Jia, Jianping Weng, Dalong Zhu, Linong Ji, Juming Lu, Zhiguang Zhou, Dajin Zou, Lixin Guo, Qiuhe Ji, Li Chen, Liming Chen, Jingtao Dou, Xiaohui Guo, Hongyu Kuang, Ling Li, Qifu Li, Xiaoying Li, Jing Liu, Xingwu Ran, Lixin Shi, Guangyao Song, Xinhua Xiao, Liyong Yang, Zhigang Zhao, On behalf of Chinese Diabetes Society - Diabetes/Metabolism Research and Reviews 2019 被引用: 763

  6. Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis

    著者: Hui Jiang, Yongwen Zhou, Seyed Mohammad Nabavi, Amirhossein Sahebkar, Peter J. Little, Suowen Xu, Jianping Weng, Jianjun Ge - Frontiers in Cardiovascular Medicine 2022 被引用: 292

  7. The role of inflammation in immune system of diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications

    著者: Tong Yue, Yu Shi, Sihui Luo, Jianping Weng, Yali Wu, Xueying Zheng - Frontiers in Immunology 2022 被引用: 194

  8. Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China

    著者: Xuhong Hou, Limin Wang, Dalong Zhu, Lixin Guo, Jianping Weng, Mei Zhang, Zhiguang Zhou, Dajin Zou, Qiuhe Ji, Xiaohui Guo, Qiang Wu, Siyu Chen, Rong Yu, Hongli Chen, Zhengjing Huang, Xiao Zhang, Jiarui Wu, Jing Wu, Weiping Jia, Jing Wu, Weiping Jia, for the China National Diabetic Chronic Complications (DiaChronic) Study Group - Nature Communications 2023 被引用: 128

  9. Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

    著者: Jinhua Yan, Bin Yao, Hongyu Kuang, Xubin Yang, Qin Huang, Tianpei Hong, Yushu Li, Jingtao Dou, Wenying Yang, Guijun Qin, Huijuan Yuan, Xinhua Xiao, Sihui Luo, Zhongyan Shan, Hongrong Deng, Ying Tan, Fen Xu, Wen Xu, Longyi Zeng, Zhuang Kang, Jianping Weng - Hepatology 2018 被引用: 252

  10. Resveratrol in Treating Diabetes and Its Cardiovascular Complications: A Review of Its Mechanisms of Action

    著者: Meiming Su, Wenqi Zhao, Suowen Xu, Jianping Weng - Antioxidants 2022 被引用: 108

  11. Prevalence of Diabetes among Men and Women in China

    著者: Wenying Yang, Juming Lu, Jianping Weng, Weiping Jia, Linong Ji, Jianzhong Xiao, Zhongyan Shan, Jie Liu, Haoming Tian, Qiuhe Ji, Dalong Zhu, Jiapu Ge, Lixiang Lin, Li Chen, Xiaohui Guo, Zhigang Zhao, Qiang Li, Zhiguang Zhou, Guangliang Shan, Jiang He - New England Journal of Medicine 2010 被引用: 3,055

  12. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

    著者: Francesco Rubino, David M. Nathan, Robert H. Eckel, Philip R. Schauer, K. G. M. M. Alberti, Paul Zimmet, Stefano Del Prato, Linong Ji, S.M. Sadikot, William H. Herman, Stephanie A. Amiel, Lee M. Kaplan, Gaspar Taroncher‐Oldenburg, David E. Cummings, Delegates of the 2nd Diabetes Surgery Summit, Nizar Albache, Rachel L. Batterham, Deepak L. Bhatt, Camilo Boza, William T. Cefalu, Ricardo V. Cohen, Anita P. Courcoulas, Seán F. Dinneen, John B. Dixon, Ele Ferrannini, Paola Fioretto, Gema Frühbeck, Michel Gagner, Richard W. Grant, Sayeed Ikramuddin, Desmond G. Johnston, Sangeeta R. Kashyap, Tracy Kelly, Tomasz Klupa, Judith Körner, Blandine Laferrère, Harold E. Lebovitz, Wei‐Jei Lee, Carel W. le Roux, Jeffrey I. Mechanick, Geltrude Mingrone, John M. Morton, Walter J. Pories, Robert E. Ratner, Gerry Rayman, Harvey J. Sugerman, Luc Van Gaal, Josép Vidal, Jianping Weng, Bruce M. Wolfe - Diabetes Care 2016 被引用: 971

  13. Kaempferol and atherosclerosis: From mechanism to medicine

    著者: Meijie Chen, Jianbo Xiao, Hesham R. El‐Seedi, Krystyna Skalicka‐Woźniak, Maria Daglia, Peter J. Little, Jianping Weng, Suowen Xu - Critical Reviews in Food Science and Nutrition 2022 被引用: 92

  14. The many faces of diabetes: a disease with increasing heterogeneity

    著者: Tiinamaija Tuomi, Nicola Santoro, Sonia Caprio, Mengyin Cai, Jianping Weng, Leif Groop - The Lancet 2013 被引用: 654

  15. Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics

    著者: Zhenghong Liu, Xiaoxuan Ma, Iqra Ilyas, Xueying Zheng, Sihui Luo, Peter J. Little, Danielle Kamato, Amirhossein Sahebkar, Weiming Wu, Jianping Weng, Suowen Xu - Theranostics 2021 被引用: 156

  16. Metformin, Macrophage Dysfunction and Atherosclerosis

    著者: Xiaojun Feng, Wenxu Chen, Xiayun Ni, Peter J. Little, Suowen Xu, Liqin Tang, Jianping Weng - Frontiers in Immunology 2021 被引用: 144

  17. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review

    著者: Fan-shun Zhang, Qing-ze He, Cheng Xue Qin, Peter J. Little, Jianping Weng, Suowen Xu - Acta Pharmacologica Sinica 2022 被引用: 133

  18. Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine

    著者: Huiling Tan, Yue Tong, Zhengfang Chen, Weiming Wu, Suowen Xu, Jianping Weng - International Journal of Biological Sciences 2022 被引用: 103

  19. Biochemical characterization of SARS-CoV-2 nucleocapsid protein

    著者: Weihong Zeng, Guangfeng Liu, Huan Ma, Dan Zhao, Yunru Yang, Muziying Liu, Ahmed Mohammed, Changcheng Zhao, Yun Yang, Jiajia Xie, Chengchao Ding, Xiaoling Ma, Jianping Weng, Yong Gao, Hongliang He, Tengchuan Jin - Biochemical and Biophysical Research Communications 2020 被引用: 527

  20. Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies

    著者: Tingyu Fang, Hua Wang, Xiaoyue Pan, Peter J. Little, Suowen Xu, Jianping Weng - International Journal of Biological Sciences 2022 被引用: 88

  21. TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase

    著者: Suowen Xu, Xiumei Wu, Sichen Wang, Mengyun Xu, Tingyu Fang, Xiaoxuan Ma, Meijie Chen, Jiajun Fu, Juan Guo, Song Tian, Tian Tian, Xu Cheng, Hailong Yang, Junjie Zhou, Zhenya Wang, Yanjun Yin, Wen Xu, Fen Xu, Jinhua Yan, Zhihua Wang, Sihui Luo, Xiao‐Jing Zhang, Yan‐Xiao Ji, Jianping Weng - Journal of Clinical Investigation 2024 被引用: 58

  22. GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1

    著者: Fen Xu, Beisi Lin, Xiaobin Zheng, Zonglan Chen, Huanyi Cao, Haixia Xu, Hua Liang, Jianping Weng - Diabetologia 2016 被引用: 148

  23. Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

    著者: Jianping Weng, Yanbing Li, Wen Xu, Lixin Shi, Qiao Zhang, Dalong Zhu, Yun Hu, Zhiguang Zhou, Xiang Yan, Haoming Tian, Xingwu Ran, Zuojie Luo, Jing Xian, Li Yan, Fangping Li, Longyi Zeng, Yanming Chen, Liyong Yang, Sunjie Yan, Juan Liu, Ming Li, FU Zu-zhi, Hua Cheng - The Lancet 2008 被引用: 769

  24. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort

    著者: Roseanne O. Yeung, Yuying Zhang, Andrea O. Y. Luk, Wenying Yang, Leorino Sobrepeña, Kun‐Ho Yoon, S. R. Aravind, Wayne Huey‐Herng Sheu, Thy Khue Nguyen, Risa Ozaki, Chaicharn Deerochanawong, Chiu Chi Tsang, Wing-Bun Chan, Eun Gyoung Hong, Trung Quan, Yu Cheung, Nicola Brown, Su Yen Goh, Ronald C.W., M. Mukhopadhyay, Arvind Kumar Ojha, Shaibal Chakraborty, Alice P.S. Kong, Winnie Lau, Weiping Jia, Wenhui Li, Xiaohui Guo, Rongwen Bian, Jianping Weng, Linong Ji, Mercedes Reyes-dela Rosa, Ronaldo M Toledo, Thep Himathongkam, Soon-Jib Yoo, C. C. Chow, Larry L-T. Ho, Lee‐Ming Chuang, Greg Tutino, Peter C.Y. Tong, Wing‐Yee So, Troels Wolthers, Gary T.C. Ko, Greg Lyubomirsky, Juliana C.N. Chan - The Lancet Diabetes & Endocrinology 2014 被引用: 302